tiprankstipranks
FDA Advisory Panel review of Guardant Health Shield Blood Test on May 23
PremiumThe FlyFDA Advisory Panel review of Guardant Health Shield Blood Test on May 23
29d ago
Guardant Health to present data on epigenomics at 2024 AACR meeting
PremiumThe Fly
Guardant Health to present data on epigenomics at 2024 AACR meeting
2M ago
Canaccord positive on Exact, Guardant after Freenome data
PremiumThe Fly
Canaccord positive on Exact, Guardant after Freenome data
2M ago
Guardant Health price target lowered to $37 from $44 at TD Cowen
PremiumThe FlyGuardant Health price target lowered to $37 from $44 at TD Cowen
3M ago
Guardant Health price target lowered to $35 from $38 at BofA
PremiumThe Fly
Guardant Health price target lowered to $35 from $38 at BofA
3M ago
Guardant Health price target lowered to $45 from $50 at Canaccord
PremiumThe Fly
Guardant Health price target lowered to $45 from $50 at Canaccord
3M ago
Guardant Health’s preliminary Q4 results well ahead of consensus, says Canaccord
PremiumThe FlyGuardant Health’s preliminary Q4 results well ahead of consensus, says Canaccord
4M ago
Guardant Health sees FY23 revenue $562M-$563M, consensus $555.18M
PremiumThe Fly
Guardant Health sees FY23 revenue $562M-$563M, consensus $555.18M
4M ago
Guardant Health reports preliminary Q4 revenue $153M-$154M, consensus $146.34M
PremiumThe Fly
Guardant Health reports preliminary Q4 revenue $153M-$154M, consensus $146.34M
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100